Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study

Overview

Journal Basic Clin Neurosci

Specialty Neurology

Date 2019 Apr 30

PMID 31031896

Citations 5

Authors

Narges Eskandari-Roozbahani

Tahoora Shomali

Mahnaz Taherianfard

Affiliations

Soon will be listed here.

Abstract

Introduction: Finding herbs with promising effects to prevent or postpone Alzheimer Disease (AD) is highly demanded. The present study aimed at clarifying plausible effects and related mechanism(s) of Zataria Multiflora Essential Oil (ZMEO) against memory impairment in a rat model of the AD.

Methods: Forty male adult rats were categorized into four groups and treated as follows: 1. The Negative Control (NC): no treatment; 2. Sham control (sham): distilled water by Intracerebroventricular (ICV) injection; 3. The AD control (AD): Aβ 1-42 by ICV injection; and 4. The ZMEO group: Aβ 1-42 by ICV injection and ZMEO at 100 μL/kg/d orally for 20 days.

Results: After Congo red staining of the hippocampus, a relative decrease in amyloid deposits was observed in the ZMEO group. Moreover, rats showed better outcomes in Morris Water Maze (MWM) test, reduced hippocampal acetylcholinesterase (AchE) activity, and higher Brain-Derived Neurotrophic Factor (BDNF) content as compared with the AD group (P<0.05). However, no significant changes in antioxidant status was observed (P>0.05).

Conclusion: ZMEO has a protective effect against memory impairment in rats with AD at least partly via reducing hippocampal AchE activity and enhancement of BDNF levels without a change in antioxidant status. These findings can pave the way for future studies on the usefulness of this herb in AD prevention.

Citing Articles

The Potential Role of Phytochemicals in Alzheimer's Disease.

Baranowska-Wojcik E, Gajowniczek-Alasa D, Pawlikowska-Pawlega B, Szwajgier D Nutrients. 2025; 17(4).

PMID: 40004981 PMC: 11858096. DOI: 10.3390/nu17040653.

Essential Oils in Experimental Models of Neuropsychiatric Disorders: A Systematic Review.

Fernandes L, Costa I, Freire M, Lima F, Idalina Neta F, de Souza Lucena E Curr Neuropharmacol. 2021; 19(10):1738-1759.

PMID: 33882807 PMC: 8977636. DOI: 10.2174/1570159X19666210421091734.

Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review.

Abd Rashed A, Abd Rahman A, Rathi D Molecules. 2021; 26(4).

PMID: 33669787 PMC: 7922935. DOI: 10.3390/molecules26041107.

Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.

Zare D, Rajizadeh M, Maneshian M, Jonaidi H, Sheibani V, Asadi-Shekaari M Psychopharmacology (Berl). 2021; 238(6):1645-1656.

PMID: 33624157 DOI: 10.1007/s00213-021-05798-8.

Neuroprotective Studies on L. Essential Oils Using Transgenic Animal Models.

Tong X, Li X, Ayaz M, Ullah F, Sadiq A, Ovais M Front Pharmacol. 2021; 11:580069.

PMID: 33584260 PMC: 7873646. DOI: 10.3389/fphar.2020.580069.

References

Sajed H, Sahebkar A, Iranshahi M . Zataria multiflora Boiss. (Shirazi thyme)--an ancient condiment with modern pharmaceutical uses. J Ethnopharmacol. 2012; 145(3):686-98. DOI: 10.1016/j.jep.2012.12.018. View

Wilcock D, Gordon M, Morgan D . Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat Protoc. 2007; 1(3):1591-5. DOI: 10.1038/nprot.2006.277. View

Fitzgerald L, Dokla C . Morris water task impairment and hypoactivity following cysteamine-induced reductions of somatostatin-like immunoreactivity. Brain Res. 1989; 505(2):246-50. DOI: 10.1016/0006-8993(89)91450-9. View

Hosseinzadeh H, Ramezani M, Salmani G . Antinociceptive, anti-inflammatory and acute toxicity effects of Zataria multiflora Boiss extracts in mice and rats. J Ethnopharmacol. 2000; 73(3):379-85. DOI: 10.1016/s0378-8741(00)00238-5. View

DiCiero Miranda M, de Bruin V, Vale M, Viana G . Lipid peroxidation and nitrite plus nitrate levels in brain tissue from patients with Alzheimer's disease. Gerontology. 2000; 46(4):179-84. DOI: 10.1159/000022156. View

Li H, Wu X, Bai Y, Huang Y, He W, Dong Z . Unilateral lesion of dorsal hippocampus in adult rats impairs contralateral long-term potentiation in vivo and spatial memory in the early postoperative phase. Behav Brain Res. 2012; 230(2):428-32. DOI: 10.1016/j.bbr.2012.02.042. View

Majlessi N, Choopani S, Kamalinejad M, Azizi Z . Amelioration of amyloid β-induced cognitive deficits by Zataria multiflora Boiss. essential oil in a rat model of Alzheimer's disease. CNS Neurosci Ther. 2011; 18(4):295-301. PMC: 6493392. DOI: 10.1111/j.1755-5949.2011.00237.x. View

Cacabelos R . Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat. 2009; 3(3):303-33. PMC: 2654795. View

Forsyth D, Surmon D, Morgan R, Wilcock G . Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study. Age Ageing. 1989; 18(4):223-9. DOI: 10.1093/ageing/18.4.223. View

10.

Lleo A, Greenberg S, Growdon J . Current pharmacotherapy for Alzheimer's disease. Annu Rev Med. 2006; 57:513-33. DOI: 10.1146/annurev.med.57.121304.131442. View

11.

Gholamipour-Badie H, Naderi N, Khodagholi F, Shaerzadeh F, Motamedi F . L-type calcium channel blockade alleviates molecular and reversal spatial learning and memory alterations induced by entorhinal amyloid pathology in rats. Behav Brain Res. 2012; 237:190-9. DOI: 10.1016/j.bbr.2012.09.045. View

12.

Fellgiebel A, Yakushev I . Diffusion tensor imaging of the hippocampus in MCI and early Alzheimer's disease. J Alzheimers Dis. 2011; 26 Suppl 3:257-62. DOI: 10.3233/JAD-2011-0001. View

13.

Zussy C, Brureau A, Delair B, Marchal S, Keller E, Ixart G . Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats. Am J Pathol. 2011; 179(1):315-34. PMC: 3123848. DOI: 10.1016/j.ajpath.2011.03.021. View

14.

Murer M, Yan Q, Raisman-Vozari R . Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol. 2000; 63(1):71-124. DOI: 10.1016/s0301-0082(00)00014-9. View

15.

Mimica N, Presecki P . Side effects of approved antidementives. Psychiatr Danub. 2009; 21(1):108-13. View

16.

Nagahara A, Merrill D, Coppola G, Tsukada S, Schroeder B, Shaked G . Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med. 2009; 15(3):331-7. PMC: 2838375. DOI: 10.1038/nm.1912. View

17.

Reddy P . Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem. 2005; 96(1):1-13. DOI: 10.1111/j.1471-4159.2005.03530.x. View

18.

Jukic M, Politeo O, Maksimovic M, Milos M, Milos M . In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone. Phytother Res. 2006; 21(3):259-61. DOI: 10.1002/ptr.2063. View

19.

Jeong J, Jeong H, Jo Y, Kim H, Shin J, Heo H . Ameliorating effects of aged garlic extracts against Aβ-induced neurotoxicity and cognitive impairment. BMC Complement Altern Med. 2013; 13:268. PMC: 4015812. DOI: 10.1186/1472-6882-13-268. View

20.

Abe E, Casamenti F, Giovannelli L, Scali C, Pepeu G . Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res. 1994; 636(1):162-4. DOI: 10.1016/0006-8993(94)90193-7. View